← Back to Search

Nonsteroidal Anti-inflammatory Drug

Ketorolac vs Oxycodone for Post-Surgical Pain After Great Toe Joint Fusion

Phase 1
Recruiting
Research Sponsored by Medstar Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 - 75 years
Primary elective great toe MTP arthrodesis (CPT 28750). Other forefoot procedures often performed in conjunction with toe fusion will be included (CPT codes 28308, 28285, 28270)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days after the surgery
Awards & highlights

Study Summary

This trial looks at whether ketorolac can help manage pain and improve healing after joint fusion surgery.

Who is the study for?
This trial is for adults aged 18-75 undergoing elective great toe joint fusion surgery, without severe kidney disease, gastric ulcers, chronic pain syndromes like CRPS or fibromyalgia, tobacco use, diabetes, drug abuse issues. They must not be pregnant or breastfeeding and should be able to understand English.Check my eligibility
What is being tested?
The study compares the effectiveness of ketorolac versus oxycodone in managing post-surgical pain after a toe joint fusion procedure. It also examines whether ketorolac impacts bone healing following the surgery.See study design
What are the potential side effects?
Ketorolac may cause stomach upset, bleeding risks, and potential kidney problems. Oxycodone can lead to nausea, constipation, drowsiness and has a risk for dependency or abuse.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 75 years old.
Select...
I am scheduled for a big toe joint fusion surgery, possibly with other toe surgeries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 14 days after the surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 14 days after the surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain scores - collected at baseline (standard of care) and for the study using a study survey on days 3, 7, and 14 after surgery.
Quantitative pain management - measured using a study survey.
Secondary outcome measures
Bone fusion
Other outcome measures
Bone fusion - doctor will review the 3 month postop x-ray to see if the bones have fused at the site of surgery

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2 (Treatment group) - Oxycodone and KetorolacExperimental Treatment2 Interventions
Subjects randomized to this group will receive oxycodone and ketorolac for postop pain management.
Group II: Group 1 (Control group) - Oxycodone onlyActive Control1 Intervention
Subjects randomized to this group will receive oxycodone for postop pain management (standard of care).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxycodone
2014
Completed Phase 4
~2210
Ketorolac
2014
Completed Phase 4
~1760

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Medstar Health Research InstituteLead Sponsor
189 Previous Clinical Trials
115,533 Total Patients Enrolled

Media Library

Ketorolac (Nonsteroidal Anti-inflammatory Drug) Clinical Trial Eligibility Overview. Trial Name: NCT05054868 — Phase 1
Joint Fusion Research Study Groups: Group 1 (Control group) - Oxycodone only, Group 2 (Treatment group) - Oxycodone and Ketorolac
Joint Fusion Clinical Trial 2023: Ketorolac Highlights & Side Effects. Trial Name: NCT05054868 — Phase 1
Ketorolac (Nonsteroidal Anti-inflammatory Drug) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05054868 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age range of participants in this study limited to individuals over sixty years old?

"The requirements for this medical trial dictate that potential participants must be aged 18 to 75. However, there are an additional 16 studies for minors and 39 trials catering to senior citizens."

Answered by AI

What therapeutic benefits has Ketorolac been observed to provide?

"Ketorolac has been shown to effectively ameliorate the signs and symptoms of acute pericarditis, ocular itching, as well ass alleviate pain."

Answered by AI

Are there any vacant slots left in this medical experiment?

"According to the clinicaltrials.gov entry, this experiment is currently enrolling participants. It was originally launched on April 14th 2020 and underwent its most recent edit on May 31st 2022."

Answered by AI

Could you please provide details about the prior experiments conducted with Ketorolac?

"At the moment, 61 distinct investigations involving ketorolac are underway – 13 of which have reached Phase 3. Most of these trials are based in Los Angeles, California though 82 other centres also host studies for this drug."

Answered by AI

How many participants are enrolled in this clinical experiment?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial is actively accepting participants, having been first posted on April 14th 2020 and most recently updated May 31st 2022. The study aims to enrol 40 patients from 2 medical centres."

Answered by AI

Is my eligibility adequate to take part in this research?

"This medical investigation is enrolling 40 individuals aged between 18 to 75 with arthrodesis. It is essential that these participants have undergone a primary elective great toe MTP arthrodesis (CPT 28750) and may have had other forefoot procedures performed in conjunction such as CPT codes 28308, 28285, or 28270."

Answered by AI

Does the FDA sanction Ketorolac for therapeutic use?

"We rate Ketorolac's safety as a 1 since this is an early-stage trial with limited data demonstrating its efficacy and security."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Ketorolac vs Oxycodone for Great Toe Arthrodesis
2020. "Ketorolac vs Oxycodone for Great Toe Arthrodesis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05054868.
~2 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top